+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Relative potency of two purified protein derivatives of bovine AN5 strain tuberculin according to living or inactivated state of guinea pigs sensitizing strain Mycobacterium bovis.1



Relative potency of two purified protein derivatives of bovine AN5 strain tuberculin according to living or inactivated state of guinea pigs sensitizing strain Mycobacterium bovis.1



Annales de recherches veterinaires = Annals of veterinary research2(4): 397-401




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 016890559

Download citation: RISBibTeXText


Related references

Relative potency of two purified protein derivatives of bovine tuberculin (AN5 strain) in relation to the live or inactive state of the strain used to sensitize guinea pigs. Annales de Recherches Veterinaires 12(4): 397-401, 1981

Relative activity of 2 purified protein derivatives of bovine tuberculin--strain AN5--according to the living or inactive state of the strain of sensitivity in the guinea pig. Annales de Recherches Veterinaires. Annals of Veterinary Research 12(4): 397-401, 1982

The potency of bovine PPD purified protein derivative tuberculins in guinea-pigs and in tuberculous cattle Mycobacterium bovis. 1983

Destruction of syngeneic tumors by tuberculin-stimulated peritoneal exudate cells from guinea pigs immunized to Mycobacterium bovis (strain BCG). Journal of the National Cancer Institute 53(2): 541-546, 1974

The standardization of the purified protein tuberculin of the mammalian type and its application in the simple tuberculin test on cattle mycobacterium tuberculosis bovis guinea pig sheep. Lucrarile Institutului de Cercetari Veterinare si Biopreparate Pasteur 1: 45-54, 1962

Mycobacterium africanum its experimental virulence and sensitizing capacity to different tuberculin purified protein derivatives. Bulletin of the International Union Against Tuberculosis 54(2): 164-165, 1979

Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin. Infection and Immunity 68(12): 7094-7099, 2000

Genetic stability of a Mycobacterium bovis strain by serial infections in guinea pigs. Tecnica Pecuaria en Mexico 42(3): 315-323, 2004

Determination of the optimum dose of some sensitins purified protein derivatives of mycobacterium tuberculosis strain 23 mycobacterium kansasii mycobacterium avium mycobacterium battey mycobacterium scrofulaceum with regard to their use in the lympho blast transformation test. Bulletin de l'Association des Diplomes de Microbiologie de la Faculte de Pharmacie de Nancy (125): 8-23, 1972

The induction of suppressor cells in strain 13 guinea pigs by mycobacterium bovis and fractions thereof. Federation Proceedings 36(3): 1271, 1977

Further studies on the potency of purified protein derivatives of tuberculin (PPD-s). 2nd report: Comparison of the potency of PPD and old tuberculin. Kekkaku 35: 618-621, 1960

Tuberculin Production. 4. Specificity Of Tuberculin Of Mycobacterium Tuberculosis And M. Bovis (Bcg Strain). Acta Pathologica et Microbiologica Scandinavica 60: 241-252, 1964

Observations on the protection conferred by bcg vaccination of guinea pigs challenged by a local strain of mycobacterium bovis. Boletim do Instituto de Pesquisas Veterinarias "Desiderio Finamor" 4: 45-52, 1977

Draft Genome Sequence of Mycobacterium bovis Strain AN5, Used for Production of Purified Protein Derivative. Genome Announcements 2(2):, 2014

Activity of different doses of tuberculin units of purified protein derivative tuberculin in cattle infected with mycobacterium bovis. Documenta Veterinaria: 9-194, 1966